Home › Funds › AMI ASSET MANAGEMENT CORP › KNSA

AMI ASSET MANAGEMENT CORP position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

AMI ASSET MANAGEMENT CORP reported holding 15,341 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$1.1M, representing 0.07% of its reported portfolio and ranking #39 among its reported holdings. AMI ASSET MANAGEMENT CORP has disclosed KNSA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)15.34K sh
Reported value held$1.14M
Portfolio Weight0.07%
First reportedQ3 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AMI ASSET MANAGEMENT CORP's KNSA position evolved

AMI ASSET MANAGEMENT CORP first disclosed a stake in KNSA in Q3 2024 at 51,262 shares (US$1.3M). The position peaked in Q4 2025 at 43,116 shares, worth US$1.8M. Across 9 filings, AMI ASSET MANAGEMENT CORP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 15,341 shares valued at US$1.1M — a reduction of -517 shares quarter over quarter.. Notable position changes include a 50% increase in Q1 2025 (shares rose 25% over the following quarter), a 44% trim in Q2 2025 (shares rose 40% over the following quarter), a 49% trim in Q1 2026 (shares rose 33% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 51.26K $1.28M New
Q4 2024 51.68K $1.02M Add
Q1 2025 77.69K $1.73M Add
Q2 2025 43.14K $1.19M Reduce
Q3 2025 43.11K $1.67M Hold
Q4 2025 43.12K $1.78M Hold
Q1 2026 21.94K $1.06M Reduce
Q2 2026 15.86K $1.01M Reduce
Q3 2026 15.34K $1.14M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 51 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has AMI ASSET MANAGEMENT CORP held KNSA?

AMI ASSET MANAGEMENT CORP has disclosed KNSA holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is AMI ASSET MANAGEMENT CORP's current position in KNSA?

As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 15.34K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $1.14M, representing 0.07% of its reported portfolio and ranking #39.

Has AMI ASSET MANAGEMENT CORP been buying or selling KNSA?

In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP reduced its position in KNSA. The position peaked in Q4 2025 at 43.12K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 51 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.